Tianafac

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C11H9ClO2S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier P0T3ZRK3XV, chemically known as benzo(b)thiophene-2-acetic acid, 5-chloro-3-methyl- but generally known as tianafac, which bears US NIH Compound Identifier 68686. European Medicines Agency schedules Tianafac in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11006MIG. The term TIANAFAC is an International Non-Proprietary Name. TIANAFAC is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule tianafac under HS 29349990 and SITC 51579. As of Q4 2014, TIANAFAC remains the US FDA Preferred Term for this commodity. Tianafac bears US NLM identifiers UMLS ID C0602554 and NCI Concept Code C76819. SMILES: CC1=C(SC2=C1C=C(C=C2)CL)CC(=O)O.